These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 24291618)

  • 1. Proton pump inhibitor usage and the associated risk of pneumonia in patients with chronic kidney disease.
    Chen CH; Lin HC; Lin HL; Lin YT; Chou JM; Hsu SP; Fung CP
    J Microbiol Immunol Infect; 2015 Aug; 48(4):390-6. PubMed ID: 24291618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based cohort study on the risk of pneumonia in patients with non-traumatic intracranial haemorrhage who use proton pump inhibitors.
    Ho SW; Tsai MC; Teng YH; Yeh YT; Wang YH; Yang SF; Yeh CB
    BMJ Open; 2014 Nov; 4(11):e006710. PubMed ID: 25384687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using proton pump inhibitors correlates with an increased risk of chronic kidney disease: a nationwide database-derived case-controlled study.
    Hung SC; Liao KF; Hung HC; Lin CL; Lai SW; Lee PC; Hung SR
    Fam Pract; 2018 Mar; 35(2):166-171. PubMed ID: 29045621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Proton Pump Inhibitors Usage with Risk of Pneumonia in Dementia Patients.
    Ho SW; Teng YH; Yang SF; Yeh HW; Wang YH; Chou MC; Yeh CB
    J Am Geriatr Soc; 2017 Jul; 65(7):1441-1447. PubMed ID: 28321840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors are associated with increased risk of development of chronic kidney disease.
    Arora P; Gupta A; Golzy M; Patel N; Carter RL; Jalal K; Lohr JW
    BMC Nephrol; 2016 Aug; 17(1):112. PubMed ID: 27487959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study.
    Hart E; Dunn TE; Feuerstein S; Jacobs DM
    Pharmacotherapy; 2019 Apr; 39(4):443-453. PubMed ID: 30779194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.
    MacLaren R; Reynolds PM; Allen RR
    JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of gastric acid-suppressive agents increases the risk of dementia in patients with upper gastrointestinal disease: A population-based retrospective cohort study.
    Lin HC; Huang KT; Lin HL; Uang YS; Ho Y; Keller JJ; Wang LH
    PLoS One; 2021; 16(3):e0249050. PubMed ID: 33765029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitors use and risk of chronic kidney disease in diabetic patients.
    Yang H; Juang SY; Liao KF
    Diabetes Res Clin Pract; 2019 Jan; 147():67-75. PubMed ID: 30500543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.
    Wijarnpreecha K; Thongprayoon C; Chesdachai S; Panjawatanana P; Ungprasert P; Cheungpasitporn W
    Dig Dis Sci; 2017 Oct; 62(10):2821-2827. PubMed ID: 28836158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
    Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
    JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitor use significantly increases the risk of cryptogenic liver abscess: a population-based study.
    Wang YP; Liu CJ; Chen TJ; Lin YT; Fung CP
    Aliment Pharmacol Ther; 2015 Jun; 41(11):1175-81. PubMed ID: 25871643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitor use represents an independent risk factor for myocardial infarction.
    Shih CJ; Chen YT; Ou SM; Li SY; Chen TJ; Wang SJ
    Int J Cardiol; 2014 Nov; 177(1):292-7. PubMed ID: 25499395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of proton pump inhibitors decreases the risk of diabetes mellitus in patients with upper gastrointestinal disease: A population-based retrospective cohort study.
    Lin HC; Hsiao YT; Lin HL; Uang YS; Cheng HW; Wang Y; Wang LH
    Medicine (Baltimore); 2016 Jul; 95(28):e4195. PubMed ID: 27428221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease.
    Klatte DCF; Gasparini A; Xu H; de Deco P; Trevisan M; Johansson ALV; Wettermark B; Ärnlöv J; Janmaat CJ; Lindholm B; Dekker FW; Coresh J; Grams ME; Carrero JJ
    Gastroenterology; 2017 Sep; 153(3):702-710. PubMed ID: 28583827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitor-related headaches: a nationwide population-based case-crossover study in Taiwan.
    Liang JF; Chen YT; Fuh JL; Li SY; Chen TJ; Tang CH; Wang SJ
    Cephalalgia; 2015 Mar; 35(3):203-10. PubMed ID: 24853165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Stroke-Associated Pneumonia With Acid-Suppressive Drugs: A Population-Based Cohort Study.
    Ho SW; Hsieh MJ; Yang SF; Yeh YT; Wang YH; Yeh CB
    Medicine (Baltimore); 2015 Jul; 94(29):e1227. PubMed ID: 26200649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of adverse outcomes in Taiwan associated with concomitant use of clopidogrel and proton pump inhibitors in patients who received percutaneous coronary intervention.
    Huang CC; Chen YC; Leu HB; Chen TJ; Lin SJ; Chan WL; Chen JW
    Am J Cardiol; 2010 Jun; 105(12):1705-9. PubMed ID: 20538118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed.
    Hermos JA; Young MM; Fonda JR; Gagnon DR; Fiore LD; Lawler EV
    Clin Infect Dis; 2012 Jan; 54(1):33-42. PubMed ID: 22100573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitors associated acute kidney injury and chronic kidney disease: data mining of US FDA adverse event reporting system.
    Wu B; Li D; Xu T; Luo M; He Z; Li Y
    Sci Rep; 2021 Feb; 11(1):3690. PubMed ID: 33574396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.